← Anjan’s notebook
← Back to anjanps.com Demo content — every figure, metric, milestone, and competitor in these documents is illustrative, not real.
← Back to all product docsReporting & Status  /  Weekly Status
Weekly Status · Hash Health

Week of May 18, 2026

On track — watching Growth Reported May 22 · Anjan P.S.

Headline metrics

Workstreams

4 workstreams · 1 red, 1 amber, 2 green
Product · Anjan 66%▸

Prescription Decoder PRD advanced to Draft 0.3 and is review-ready. MVP hardening slipped — the onboarding drop-off fix didn't ship, which is why retention stayed flat. AMBER

  • Prescription Decoder PRD at Draft 0.3 — requirements, flow, and metrics locked.
  • Photo-analysis crash on HEIC imports patched and released.
  • Onboarding drop-off fix slipped a week — competing with outreach for founder time.
  • Decoder confidence threshold (open question) still unresolved — blocks R6 build.
Platform · Anjan 74%▸

Interaction engine v2 hit its key milestone — the time-aware refactor is merged, which unblocks both the Decoder and taper tracking. GREEN

  • Interaction engine v2 — time-aware refactor merged to main.
  • Engine now accepts records from any source (manual / decoded / imported).
  • VVSS scoring framework — first spec draft started.
Growth · Anjan 30%▸

The clinical outreach pilot made no progress this week — zero clinic conversations. Founder bandwidth was fully absorbed by Product and Fundraising. This is the headline risk. RED

  • No clinic outreach conversations held — target was three.
  • Outreach is consistently the workstream that loses the time trade-off.
  • Web/PWA contractor brief drafted, ready to send.
Fundraising · Anjan 80%▸

Pre-seed prep is nearly done. Narrative, founder-market-fit doc, and deck final draft are all complete — on track to open the round in Q3. GREEN

  • Investor narrative finalised.
  • Founder-market-fit doc complete.
  • Pre-seed deck — final draft done; one design pass remaining.

Wins · Risks · Next week

✓Wins
  • Interaction engine v2 refactor merged — unblocks the Decoder.
  • MRR crossed $91 (+5.8% WoW); users at 178 (+6.6%).
  • Pre-seed deck final draft complete.
!Risks
  • Clinical outreach made zero progress — second week running.
  • 4-week retention flat at 28%; onboarding fix slipped.
  • Decoder confidence threshold still undecided.

Open blockers

HIGH
Founder bandwidth — outreach loses every trade-off
With a single part-time founder, Growth is consistently deprioritised against Product and Fundraising. Two straight weeks of no outreach.
Owner: Anjan · Action: ring-fence a fixed weekly outreach block, or accept Growth stays paused until after the raise.
MED
Gemini Vision cost per decode is unmodelled
Prescription Decoder unit economics are unknown. Per-decode inference cost scales directly with the 45% activation target.
Owner: Anjan · Action: cost model due next week, before Decoder build starts.
MED
Web / PWA needs a second pair of hands
The Web/PWA build can't run on founder time alone. Contractor brief is drafted but not yet sent.
Owner: Anjan · Action: send contractor brief; target a start before Q3.
LOW
Decoder test-label set under-represents regional pharmacies
The 200-label OCR test set skews to national chains; regional label layouts may be under-tested before GA.
Owner: Product · Action: expand the set before the Decoder GA milestone.